Adverse effects of benzalkonium chloride on the nasal mucosa: Allergic rhinitis and rhinitis medicamentosa

Clinical Therapeutics

Volumn 21, Issue 10, 1999, Pages 1749-1755

  Graf, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergic rhinitis; Benzalkonium chloride; Oxymetazoline; Preservatives; Rhinitis medicamentosa; Topical nasal decongestants

Indexed keywords

BENZALKONIUM CHLORIDE; OXYMETAZOLINE;

ALLERGIC RHINITIS; BACTERICIDAL ACTIVITY; BRONCHOSPASM; DRUG EFFICACY; HUMAN; NOSE CONGESTION; NOSE MUCOSA; REVIEW; STEREOMETRY;

EID: 0032745765     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(99)80053-8     Document Type: Note

References (22)

1. 1. Adams PF, Marano MA. Current Estimates from the National Health Interview Survey, 1994: Vital and Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1995. US Department of Health and Human Services Publication (PHS) 96-1521, Series 10, No. 193.
2. 2. Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin lmmunol. 1997;99(Suppl):S808-S814.
3. 3. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy, 1994; 731:35-39.
4. 4. Wright AL, Holberg CJ, Martinez FD, et al. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94:895-901.
5. 5. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: A 23-year follow-up of college students. Allergy Proc. 1984;15:21-25.
6. 6. Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997;107:40-43.
7. 7. Graf P, Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope. 1996;106: 605-609.
8. 8. Suh SH, Chon K, Min Y-G, et al. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Acta Otolaryngol (Stockh). 1995; 115:664-671.
9. 9. Graf P. Rhinitis medicamentosa: Aspects of pathophysiology and treatment. Allergy. 1997;52(Suppl 40):28-34.
10. 10. Petruson B, Hansson H-A. Function and structure of the nasal mucosa after 6 weeks' use of nose-drops. Acta Otolaryngol (Stockh). 1982;94:563-569.
11. 11. American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: Update. Pediatrics. 1997;99:268-278.
12. 12. McMahon C, Darby Y, Ryan R, Scadding G. Immediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivo. Clin Otolaryngol. 1997; 22:318-322.
13. 13. Miszkiel KA, Beasley R, Rafferty P, Holgate ST. The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br J Clin Pharmacol. 1988;25:157-163.
14. 14. Bjerknes R, Steinsvåg K. Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decongestive nosedrops. Pharmacol Toxicol. 1993;73:41-45.
15. 15. Batts A, Marriot C, Martin G, Bond S. The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol. 1989;41: 156-159.
16. 16. Fräki J, Kalimo K, Tuohimaa P, Aantaa G. Contact allergy to various components of topical preparations for treatment of external otitis. Acta Otolaryngol (Stockh). 1985;100:414-418.
17. 17. Lacroix JS. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand. 1989;581(Suppl):1-63.
18. 18. Elwany SS, Stephanos WM. Rhinitis medicamentosa. An experimental histopathological and histochemical study. ORL. 1983;4:187-194.
19. 19. Juto J, Lundberg C. An optical method for determining changes in mucosal congestion in the nose in man. Acta Otolaryngol (Stockh). 1982;94:149-156.
20. 20. Hallen H. Nasal Mucosa Reactivity in Healthy Subjects, in Patients with Non-allergic Nasal Hyperreactivity, and in Patients with Nasal Polyps. Stockholm: Karolinska Institute; 1994. Thesis.
21. 21. Graf P, Hallen H, Juto J-E. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy. 1995:25: 395-400.
22. 22. Hallen H, Graf P. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Clin Exp Allergy. 1995;25:401-405.